Pain Relief Patches

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

The product is contraindicated in the following situations:

Use is not recommended on wounds or damaged skin due to the potential for irritation or adverse reactions. Additionally, the application of this product in conjunction with a heating pad is contraindicated, as it may lead to increased risk of burns or skin damage. Furthermore, individuals with known allergies to any ingredients in this product should avoid its use to prevent allergic reactions.

Warnings and Precautions

Patients should be advised of the following warnings and precautions prior to using this product.

Allergy Alert Individuals with a history of allergic reactions to aspirin or salicylates are strongly encouraged to consult a healthcare professional before using this product.

General Precautions This product should not be applied to wounds or damaged skin to prevent further irritation or complications. Additionally, it is contraindicated to use this product in conjunction with a heating pad, as this may exacerbate adverse effects. Patients must also refrain from using the product if they are allergic to any of its ingredients.

Emergency Medical Help In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center.

Discontinuation and Consultation Patients should discontinue use and contact their healthcare provider if they experience any of the following: rash, itching, or excessive skin irritation; worsening of their condition; or if symptoms persist beyond 7 days or resolve only to recur within a few days.

Side Effects

Patients should be aware of the potential for allergic reactions, particularly if they have a history of sensitivity to aspirin or salicylates. It is advisable for these individuals to consult a healthcare professional prior to use.

In the event that patients experience a rash, itching, or excessive skin irritation, they should discontinue use and seek medical advice. Additionally, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, it is important to consult a doctor for further evaluation and management.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. It is essential to keep the product out of reach of children, as used patches still contain the drug and can pose serious risks if chewed or ingested by children or pets. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For patients aged 12 years and older, the recommended application involves cleaning and drying the affected area before applying the patch. The patch should be applied to the affected area no more than 3 to 4 times daily and should be removed after a maximum of 8 hours of use. Proper disposal of used patches is crucial to prevent accidental exposure to children and pets.

Geriatric Use

Elderly patients may not have specific recommendations regarding age considerations, dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the potential for altered pharmacokinetics and pharmacodynamics in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. Potential risks to the fetus are not clearly defined; therefore, caution is advised. There are no specific dosage modifications for pregnant individuals. This product should be used only if clearly needed and after a thorough discussion with a healthcare provider regarding the potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the lack of data necessitates careful clinical judgment regarding the use of the medication in individuals with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and efficacy of treatment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant clinical guidelines for specific management protocols tailored to the substance involved.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain alert to potential overdose symptoms, and implement appropriate management strategies in the event of an overdose scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions: rash, itching, and excessive skin irritation. Additionally, serious adverse effects may occur if a child or pet chews or ingests a used patch. These events have been reported voluntarily or through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed of the potential for allergic reactions and advised not to use the product if they are allergic to any of its ingredients. They should be instructed to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be made aware that they should stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Healthcare providers should emphasize the importance of using the product only as directed and advise patients to avoid contact with eyes, mucous membranes, or rashes. Patients should also be cautioned against tightly bandaging the area where the product is applied and against using it simultaneously with other topical analgesics.

Finally, it is crucial to instruct patients on the proper disposal of used patches, ensuring they are kept out of reach of children and pets, as these patches may still contain the drug product, which can lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and effectiveness.

After use, the patch must be disposed of properly to prevent access by children and pets, ensuring safety in the environment.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. The patch should be removed after a maximum application time of 8 hours. For children under 12 years of age, consultation with a physician is advised.

Clinicians should counsel patients on several important safety measures. Individuals with a history of allergic reactions to aspirin or salicylates should consult a doctor prior to use. Used patches must be disposed of properly to prevent accidental exposure to children and pets, as they still contain active drug that could lead to serious adverse effects if ingested. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur shortly after resolution. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if swallowed.

Drug Information (PDF)

This file contains official product information for Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)